(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed cash-and-stock deal would be the largest
CBD Products & CBD Business News
A key market regulator for trade in the European Union has updated its guidelines to add plant-derived CBD as a legal ingredient in cosmetics. The change comes after the European Industrial Hemp Association pointed out that the European Court of Justice recently ruled that CBD should not be classified as a drug and can be
Federal regulators that go after companies for false advertising recently weighed on sanctions against CBD companies, with one urging the agency to focus on opioid manufacturers and another warning against a chilling effect on legitimate cannabis research. Rohit Chopra and Christine S. Wilson, two of five members on the Federal Trade Commission, recently published statements
The U.S. Drug Enforcement Administration is asking a federal judge to dismiss a lawsuit from the Hemp Industries Association over an extraction rule that meany fear will wrongly criminalize temporary byproducts of the plant during production. The DEA says in a filing Tuesday that HIA is challenging “a hypothetical regulation or policy concerning manufacturing byproduct”
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Larry and Jackie Berg are co-founders of CBD Marketing Hub, a digital-to-door agency focused on CBD and cannabis marketing.) Seismic advancements have dominated the CBD market over the past decade with some of the industry’s largest brands seeing
The American Trade Association for Cannabis and Hemp, an industry trade and advocacy organization, has formed a new Cannabis Beverage Council to connect cannabis industry and beverage industry leaders focused on expanding the cannabis beverage segment. Hemp-derived CBD beverages will be a growing segment among consumers, accounting for up to $1.3 billion in sales by
A Swiss CBD company is accusing e-cigarette maker Juul of infringing on one of its patents. SwissX alleges in a lawsuit that Juul pods copy a nicotine vapor delivery system that SwissX bought the rights to last year, according to Law 360. The lawsuit was filed in Delaware federal court. SwissX, which is owned by
Hemp businesses walk a fine line when describing the health benefits of their products: Make a claim without evidence or wording that misleads consumers, and soon the legal fees will pile up. The U.S. Food and Drug Administration has guidelines for acceptable claims to make on labels for dietary supplements – the closest fit for
A cosmetics executive has been tapped to take over California CBD manufacturer Papa & Barkley. Evelyn Wang replaces Adam Grossman as CEO. Grossman will lead the company’s board of directors. Wang comes from Milani Cosmetics. She was formerly an assistant vice president for L’Oreal Paris, and before that was Product Director for Neutrogena Cosmetics, part
U.S. drug regulators have withdrawn their proposal to regulate over-the-counter CBD, handing the industry another setback after years of delay from the Food and Drug Administration. The proposal in question appears to be on pause because of the changing administration. The delay was widely anticipated but still frustrating for CBD operators awaiting the rules. The
